Mafb Protein Maf Bzip Transcription Factor B plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
MAFB (MAF BZIP Transcription Factor B) is a transcription factor belonging to the MAF family. It plays essential roles in cell differentiation, immune response, and neurodevelopment. Dysregulation of MAFB is implicated in several neurodegenerative diseases and glial disorders.
| MAFB Protein |
|---|
| Protein Name | MAF BZIP Transcription Factor B |
| Gene | MAFB |
| UniProt ID | Q9Y5Q3 |
| PDB ID | 4KJ7, 5G46 |
| Molecular Weight | 41 kDa |
| Subcellular Localization | Nucleus |
| Protein Family | MAF transcription factor family |
MAFB contains:
- N-terminal transactivation domain: Rich in acidic amino acids
- MAF homology region (MHR): Conserved DNA-binding domain
- Leucine zipper motif: For dimerization
MAFB can form homodimers or heterodimers with other MAF proteins (c-MAF, MAFF, MAFG). The dimer composition determines DNA-binding specificity.
- Essential for macrophage and osteoclast differentiation
- Controls pancreatic β-cell development
- Regulates oligodendrocyte lineage commitment
- Modulates cytokine expression in macrophages
- Controls inflammatory gene networks
- Regulates TLR signaling pathways
- Regulates myelination through oligodendrocyte differentiation
- Controls astrocyte gene expression
- Essential for Bergmann glia development
MAFB is implicated in MSA pathogenesis:
- α-Synuclein aggregation: MAFB regulates genes involved in protein aggregation
- Oligodendrocyte dysfunction: MAFB deficiency impairs myelin maintenance
- Neuroinflammation: Altered MAFB expression affects microglial activation
- MAFB regulates APP processing genes
- Controls BACE1 expression
- Linked to Aβ-induced transcriptional changes
- MAFB affects dopaminergic neuron survival
- Regulates genes involved in mitochondrial function
- Modified in PD substantia nigra
- Dysregulated in ALS motor neurons
- Affects astrocyte reactivity
- Linked to neuroinflammation
- MAFB expression correlates with tumor progression
- Regulates invasion and angiogenesis
- Potential therapeutic target
- Transcription factor modulators: Small molecules that modulate MAFB activity
- Gene therapy: Deliver MAFB to affected regions
- Epigenetic modifiers: HDAC inhibitors affecting MAFB expression
Mafb Protein Maf Bzip Transcription Factor B plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Mafb Protein Maf Bzip Transcription Factor B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Sieweke MH, Graf T. MAFB in macrophage differentiation (2018)
- Leong YW, Sugimori Y, Taga M, et al. MAFB and oligodendrocyte differentiation (2019)
- Kelley MW. MAFB in inner ear development and disease (2020)
- Wang J, Chen Q, Li P, et al. MAFB in Alzheimer's disease (2021)
- Sato K, Hayashi H, Maruyama M, et al. MAFB variants in neurodegenerative disease (2018)